CANCERTOOL

» Saioa Garcia Longarte

Member of the Cancer Cell Signaling And Metabolism Lab. Biomedical engineer that works as a developer of bioinformatic tools and data analyst.
Contact her: email
More

» Arkaitz Carracedo

Responsible of a research unit in molecular oncology, where the main objective is to study the unique biological features of cancer cells in vitro and in vivo, with an emphasis on the alterations in cellular metabolism.
Contact him: email
More

» Ana M. Aransay

Responsible of the Genome Analysis Platform at CIC bioGUNE (Derio, Spain) where the main objectives are to set up state-of-the-art high throughput technologies for characterization of genomes from different points of view.
Contact her: email
More

» Ana Rosa Cortazar

Former member of the Genome Analysis Platform and of a in molecular oncology research unit, where, thanks to her background in Computer Science and Bioinformatics, she worked as a bioinformatics tool developer and data analyst.

CIC bioGUNE (Center for Cooperative Research in Biosciences), a non-profit biomedical research organization, founded in 2002 at the initiative of the Department of Industry of the Basque Government, opened its research facilities at the Technology Park of Bizkaia in January 2005. Since then, CIC bioGUNE has been playing a strong role in advancing biomedical research and technological innovation in the Basque Country. To support the research activities of The Center's scientists and students CIC bioGUNE made an investment of more than 35 million € in state-of-the-art research infrastructure - in genomics, gene silencing, proteomics, metabolomics, NMR, electron microscopy, X-ray diffraction, and computer and animal facilities, among others. Every year, The Center commits more than 5.5 million € to research and dedicates 450 thousand € to Ph.D. training. It employs 22 research group leaders, more than 85 postdocs, technicians and engineers, and provides training opportunities to over twenty Ph.D. students each year.

ERC Starting Grants aim to support up-and-coming research leaders who are about to establish a proper research team and to start conducting independent research in Europe. The scheme targets promising researchers who have the proven potential of becoming independent research leaders. It will support the creation of excellent new research teams.

The generation and review of Cancertool is supported by:
ERC-2012-STG - CancerMetab - 336343
ERC-2018-COG - CancerADAPT – 819242

The Center for Biomedical Research Network Consortium, M.P, (CIBER), more specifically, its Cancer Thematic Area (CIBERONC) was created at the beginning of 2017 and is made up of 50 research groups belonging to 27 institutions consortiums among hospitals, universities and research centers. The groups work together in six major Research Programs: Colon and digestive tract cancer; Breast cancer; Lung and respiratory tract cancer; Hematologic tumors; Tumors of low prevalence; and Molecular mechanisms of tumor progression.